Emerging data suggest this peptide, a dual stimulator targeting both GLP-1 and another hormone, may represent a significant step forward for body loss . Early patient trials have indicated substantial decreases in body mass , potentially surpassing current body composition treatments. Despite this, more assessment is necessary to fully assess its l